Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research（2023）
摘要
Anlotinib combined with temozolomide is efficacious and tolerated in recurrent GBM patients.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要